Global Microbiome Sequencing Services Market 2018-2022 - Market to Grow at a CAGR of 22.10% - ResearchAndMarkets.com

DUBLIN--()--The "Global Microbiome Sequencing Services Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The global microbiome sequencing services market to grow at a CAGR of 22.10% during the period 2018-2022.

Global Microbiome Sequencing Services Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one driver in the market is rise in chronic and infectious diseases. Over the years, the prevalence of chronic and infectious diseases such as malaria, tuberculosis, HIV AIDS, and hepatitis has increased rapidly. For instance, according to the CDC, 3.2 billion people around the world are at risk of malaria.

One trend in the market is growing awareness of microbiome in cancer development and therapy. The knowledge regarding interactions between host and microbiome can help with understanding the impact which microbes have on human health. Microbes can have both positive and negative impact on health and hence, this knowledge can help researchers understand the contribution of the microbiome community in both cancer development as well as its therapy.

Key vendors

  • BGI
  • Clinical-Microbiomics
  • Diversigen
  • GATC Biotech
  • Second Genome

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER

  • Overview
  • Comparison by end-user
  • Pharmaceutical and biotechnology companies
  • Academic institutes and research laboratories
  • Others
  • Market opportunity by end-user

PART 09: REGIONAL LANDSCAPE

  • Overview
  • Regional comparison
  • Americas
  • EMEA
  • APAC
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

  • Growing awareness of microbiome in cancer development and therapy
  • Growing demand for highly accurate forensic tools
  • Increasing adoption of microbiome sequencing in clinical workflows

PART 13: VENDOR LANDSCAPE

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Other prominent vendors

PART 15: APPENDIX

For more information about this report visit https://www.researchandmarkets.com/research/3hc6vv/global_microbiome?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biopharmaceuticals

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biopharmaceuticals